ACTA BIOCHIMICA ET BIOPHYSICA SINICA

Scope & Guideline

Fostering Global Collaboration in Biochemistry and Biophysics.

Introduction

Delve into the academic richness of ACTA BIOCHIMICA ET BIOPHYSICA SINICA with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN1672-9145
PublisherSCIENCE PRESS
Support Open AccessYes
CountryUnited Kingdom
TypeJournal
Convergefrom 1996 to 2024
AbbreviationACTA BIOCH BIOPH SIN / Acta Biochim. Biophys. Sin.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address16 DONGHUANGCHENGGEN NORTH ST, Building 5, Room 411, BEIJING 100009, PEOPLES R CHINA

Aims and Scopes

ACTA BIOCHIMICA ET BIOPHYSICA SINICA focuses on the biochemical and biophysical aspects of biological processes, offering insights into molecular mechanisms underlying various diseases and therapeutic approaches.
  1. Glycosylation and its Implications:
    The journal has a strong emphasis on the role of glycosylation in disease mechanisms, particularly in cancer and neurodegenerative diseases. This includes studies on glyco-signatures and post-translational modifications that influence cellular functions.
  2. Cancer Biology and Therapeutics:
    A significant portion of the research is dedicated to understanding cancer biology, including tumor microenvironments, resistance mechanisms, and potential therapeutic targets. The journal publishes studies on cellular signaling pathways involved in cancer progression.
  3. Immunology and Inflammation:
    The journal covers research related to immune responses in various contexts, including cancer immunotherapy, autoimmune diseases, and inflammatory responses. This includes studies on macrophage polarization and the role of immune cells in disease progression.
  4. Metabolism and Disease:
    Research on metabolic pathways and their implications in diseases such as diabetes, obesity, and cardiovascular diseases is prevalent. This includes studies on metabolic reprogramming in cancer and the impact of dietary components on health.
  5. Molecular Mechanisms and Target Identification:
    The journal emphasizes the molecular mechanisms of action for various compounds, including natural products and synthetic drugs, aiming to identify new therapeutic targets for disease management.
Recent publications in ACTA BIOCHIMICA ET BIOPHYSICA SINICA reveal several emerging themes that indicate a shift towards more innovative and relevant areas of research.
  1. Glycosylation as a Therapeutic Target:
    Research on glycosylation has surged, particularly in its role in cancer and immune responses. This includes studies that explore glycosylation patterns as potential biomarkers and therapeutic targets, highlighting its significance in personalized medicine.
  2. Metabolic Reprogramming in Cancer:
    There is a growing focus on the intersection of metabolism and cancer biology, with studies exploring how metabolic changes drive tumorigenesis and treatment resistance. This area is increasingly relevant as researchers seek to understand cancer metabolism for therapeutic interventions.
  3. Cellular Mechanotransduction:
    Emerging studies are focusing on how mechanical forces influence cellular behavior, particularly in cancer and tissue regeneration. This theme reflects an interdisciplinary approach combining biology, physics, and engineering to understand cellular responses.
  4. Role of Non-Coding RNAs:
    Research on non-coding RNAs, particularly in the context of cancer and metabolic diseases, is gaining momentum. These studies are exploring their roles in gene regulation and potential as therapeutic targets.
  5. Immunotherapy and Immune Modulation:
    There is a significant increase in research related to immunotherapy, particularly in relation to cancer treatment. This includes studies on immune checkpoint inhibitors, CAR-T cell therapies, and the modulation of immune responses to enhance therapeutic efficacy.

Declining or Waning

While ACTA BIOCHIMICA ET BIOPHYSICA SINICA maintains a broad focus, certain themes have shown a decline in prominence in recent publications, reflecting shifts in research interests.
  1. Traditional Medicinal Approaches:
    There has been a noticeable decrease in studies exclusively focused on traditional Chinese medicine compared to previous years. This may suggest a shift towards more modern, mechanistic studies that integrate traditional knowledge with contemporary scientific methods.
  2. Basic Biochemical Techniques:
    Research that primarily focuses on basic biochemical techniques without application to specific diseases or therapeutic contexts appears to be waning. There is a trend towards more applied research that connects biochemical findings with clinical relevance.
  3. Animal Models in Basic Research:
    The use of animal models for purely basic research has seen a decline, likely due to increasing emphasis on translational research and the need for more human-relevant models that can better predict clinical outcomes.

Similar Journals

CELLULAR & MOLECULAR BIOLOGY LETTERS

Fostering Collaboration in the World of Molecular Discoveries
Publisher: BMCISSN: 1425-8153Frequency: 1 issue/year

CELLULAR & MOLECULAR BIOLOGY LETTERS, published by BMC, is a premier open-access journal dedicated to disseminating high-quality research in the fields of Biochemistry, Cell Biology, and Molecular Biology. Established in 1996, the journal has emerged as a leader in its domain, boasting an impressive Q1 ranking across three critical categories as of 2023, reflecting its significant impact within the scientific community. With an ISSN of 1425-8153 and an E-ISSN of 1689-1392, it offers accessible research findings to a global audience, having been open access since 2013. Situated in the United Kingdom, at CAMPUS, 4 CRINAN ST, LONDON N1 9XW, the journal continues to serve as a vital resource for researchers, professionals, and students, contributing to advancements in the understanding of cellular and molecular processes. By providing a platform for original research, reviews, and short communications, CELLULAR & MOLECULAR BIOLOGY LETTERS plays a crucial role in fostering dialogue and collaboration within the scientific community.

Biochemistry and Cell Biology

Illuminating pathways in biochemistry and cell biology research.
Publisher: CANADIAN SCIENCE PUBLISHINGISSN: 0829-8211Frequency: 6 issues/year

Biochemistry and Cell Biology, published by Canadian Science Publishing, is a prestigious journal that has been instrumental in advancing the fields of biochemistry, molecular biology, and cell biology since its inception in 1986. With an impressive scope spanning innovative research findings to comprehensive reviews, this journal serves as a vital resource for researchers, professionals, and students alike. Currently positioned in the Q2 quartile in Biochemistry and Q3 quartiles in both Cell Biology and Molecular Biology, it reflects a robust contribution to scientific discourse, placing it among reputable publications in its field. The journal boasts notable rankings within the Scopus database, highlighting its impact and relevance, and continues to be a valuable platform for disseminating pivotal research. By providing access to a wide array of articles, the journal remains committed to fostering knowledge and collaboration in the scientific community.

FEBS Journal

Advancing the Frontiers of Biochemical Research
Publisher: WILEYISSN: 1742-464XFrequency: 24 issues/year

FEBS Journal is a prestigious, peer-reviewed publication dedicated to advancing the field of biochemistry, cell biology, and molecular biology. Published by WILEY in the United Kingdom, this journal boasts an impressive impact factor and ranks in the top quartile (Q1) across multiple relevant categories, including Biochemistry, Cell Biology, and Molecular Biology, reflecting its significant contribution to scientific research. With an ISSN of 1742-464X and an E-ISSN of 1742-4658, the FEBS Journal publishes original research and comprehensive reviews that push the boundaries of knowledge and innovation in the biosciences. As a vital resource for researchers, professionals, and students alike, the journal offers Open Access options, ensuring that cutting-edge discoveries are accessible to a broad audience. With a publication history converging from 2005 to the present and a robust emphasis on high-quality scholarly work, the FEBS Journal remains an essential platform for the dissemination of significant findings and advancements in the life sciences.

BIOCHEMICAL JOURNAL

Fostering Innovation in Biochemistry and Beyond
Publisher: PORTLAND PRESS LTDISSN: 0264-6021Frequency: 24 issues/year

BIOCHEMICAL JOURNAL, published by Portland Press Ltd, stands as a leading publication in the fields of Biochemistry, Cell Biology, and Molecular Biology, reflecting a commitment to advancing scientific knowledge since its inception in 1945. With a distinguished Q1 ranking across these categories and impressive Scopus rankings, the journal serves as an invaluable resource for researchers, professionals, and students alike, facilitating critical discoveries and innovative research practices. Although not currently offering open access, the journal provides a platform for high-quality peer-reviewed articles, ensuring rigorous standards in the dissemination of biochemical research. Spanning over seven decades and continuing through to 2024, the BIOCHEMICAL JOURNAL fosters an environment where cutting-edge biochemical research thrives, supporting the global scientific community's efforts to address complex biological questions and enhance our understanding of fundamental cellular processes.

BMB Reports

Shaping the Future of Health Through Science
Publisher: KOREAN SOCIETY BIOCHEMISTRY & MOLECULAR BIOLOGYISSN: 1976-6696Frequency: 12 issues/year

BMB Reports is a distinguished open-access journal published by the Korean Society of Biochemistry & Molecular Biology since 2008, making significant contributions to the fields of biochemistry, molecular biology, and medicine. With a current impact factor that positions it in the Q2 category for Biochemistry and Q1 for Miscellaneous Medicine, this journal supports a wide dissemination of high-quality research findings, fostering robust dialogue among researchers, professionals, and students alike. Based in Seoul, South Korea, BMB Reports aims to publish innovative studies that advance our understanding of biochemical and molecular processes, thus shaping the future of health and medicine. The journal's commitment to open access enhances the visibility of its articles, allowing for greater accessibility and engagement in the scientific community. With notable rankings in both the Biochemistry and Molecular Biology categories, BMB Reports stands as a vital resource for those seeking to stay at the forefront of research in these rapidly evolving disciplines.

Biochemistry and Biophysics Reports

Charting new territories in molecular and cellular biology.
Publisher: ELSEVIERISSN: 2405-5808Frequency: 4 issues/year

Biochemistry and Biophysics Reports, published by Elsevier, serves as a vital platform for the dissemination of innovative research in the fields of biochemistry, biophysics, cell biology, and molecular biology. With an Open Access model initiated in 2015, this journal aims to facilitate the unimpeded sharing of knowledge, allowing researchers, professionals, and students free access to significant findings and developments. The journal has established a presence in the academic community, currently holding a Q3 ranking in Biochemistry, Q2 in Biophysics, alongside its Q3 standings in both Cell Biology and Molecular Biology categories for 2023. These metrics underscore its commitment to quality and relevance, garnering attention with Scopus ranks reflecting its emerging influence. Located in the Netherlands, Biochemistry and Biophysics Reports continues to foster dialogue and collaboration among the scientific community through high-quality research outputs, contributing to advancements in understanding the intricate biochemical processes and biophysical principles that underpin life sciences.

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Elevating the Standards of Biochemical Research
Publisher: Cell Physiol Biochem Press GmbH & CoISSN: 1015-8987Frequency: 6 issues/year

Cellular Physiology and Biochemistry is a premier Open Access journal published by the prestigious Cell Physiol Biochem Press GmbH & Co, dedicated to advancing research in the fields of physiology, biochemistry, and molecular biology. Since its inception in 1987 and transitioning to an Open Access model in 2013, the journal has established itself as a vital resource for the dissemination of high-quality research and reviews, showcasing innovative methodologies and groundbreaking findings in cellular processes. With an impressive ranking in the 2023 Scopus category as Q2 in Physiology and a robust percentile of 61, Cellular Physiology and Biochemistry is committed to fostering academic dialogue among researchers, professionals, and students alike. This journal not only provides unrestricted access to its articles, but also promotes the global sharing of knowledge, which is essential for the advancement of our understanding in these vital scientific areas. The journal's editorial team is dedicated to ensuring the highest standards of academic rigor and relevance, making it an indispensable addition to the libraries of those engaged in the life sciences.

CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY

Pioneering Reviews for Tomorrow's Discoveries
Publisher: TAYLOR & FRANCIS LTDISSN: 1040-9238Frequency: 6 issues/year

Welcome to Critical Reviews in Biochemistry and Molecular Biology, a premier academic journal published by Taylor & Francis Ltd, dedicated to advancing the fields of biochemistry and molecular biology. With an impressive impact factor and a Q1 ranking in both Biochemistry and Molecular Biology for 2023, this journal serves as a vital resource for researchers, professionals, and students eager to engage with cutting-edge reviews and analyses that synthesize the latest developments in these dynamic areas of study. Since its inception in 1972, the journal has maintained a commitment to high-quality scholarship, providing a platform for critical discussions that accelerate the discovery and understanding of biochemical processes and molecular interactions. Although not open access, its robust editorial peer-review process ensures that published articles meet the highest standards of scientific rigor, making it a trusted source for the scientific community. As we continue to converge toward 2024, we invite you to explore the extensive array of topics and findings that have shaped contemporary biochemistry and molecular biology.

FASEB BioAdvances

Exploring Breakthroughs in Biological Research
Publisher: WILEYISSN: Frequency: 12 issues/year

FASEB BioAdvances, published by WILEY, is an esteemed open-access journal dedicated to advancing the fields of biochemistry, molecular biology, and physiology. Since its inception in 2019, the journal has rapidly established a significant presence within the academic community, boasting an impressive impact factor reflective of its Q2 and Q3 standings across various categories, including Biochemistry, Genetics and Molecular Biology, Cancer Research, Molecular Medicine, and Physiology. The journal aims to disseminate high-quality research and innovative findings to enhance the understanding of biological processes, making it a vital resource for researchers, professionals, and students alike. With its commitment to open access, FASEB BioAdvances ensures that groundbreaking research is available to a global audience, facilitating collaboration and exploration in these rapidly evolving scientific domains.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Bridging Research and Innovation in Life Sciences
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 1357-2725Frequency: 12 issues/year

The International Journal of Biochemistry & Cell Biology, published by Pergamon-Elsevier Science Ltd, stands as a pivotal resource in the fields of biochemistry and cell biology. With an ISSN of 1357-2725 and an E-ISSN of 1878-5875, this prestigious journal has been a key platform for disseminating cutting-edge research since its inception in 1995. The journal currently holds an impressive Q1 ranking in Biochemistry and a Q2 ranking in Cell Biology for the year 2023, reflecting its commitment to high-quality research and its influence within the scientific community. With a significant Scopus ranking of 94/438 in Biochemistry and 96/285 in Cell Biology, the journal plays a crucial role in advancing knowledge and fostering innovative approaches in these dynamic fields. Though it is not an open-access journal, the International Journal of Biochemistry & Cell Biology remains accessible to a wide audience, making it a vital resource for researchers, professionals, and students alike, who are eager to explore and contribute to the ongoing advancements in biochemistry and cell biology.